159 related articles for article (PubMed ID: 32224527)
1. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
Xu K; He J; Zhang J; Liu T; Yang F; Ren T
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
[TBL] [Abstract][Full Text] [Related]
3. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
[TBL] [Abstract][Full Text] [Related]
4. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
[TBL] [Abstract][Full Text] [Related]
5. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
8. LSF expression and its prognostic implication in colorectal cancer.
Jiang H; Du J; Jin J; Qi X; Pu Y; Fei B
Int J Clin Exp Pathol; 2014; 7(9):6024-31. PubMed ID: 25337247
[TBL] [Abstract][Full Text] [Related]
9. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Chen F; Li Z; Zhou H
J Cell Biochem; 2019 Jun; 120(6):9839-9849. PubMed ID: 30536901
[TBL] [Abstract][Full Text] [Related]
11. Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma.
Ho YJ; Lin YM; Huang YC; Chang J; Yeh KT; Lin LI; Gong Z; Tzeng TY; Lu JW
APMIS; 2017 Nov; 125(11):985-995. PubMed ID: 28913972
[TBL] [Abstract][Full Text] [Related]
12. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
[TBL] [Abstract][Full Text] [Related]
13. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
[TBL] [Abstract][Full Text] [Related]
16. A methylation-driven gene panel predicts survival in patients with colon cancer.
Peng Y; Zhao J; Yin F; Sharen G; Wu Q; Chen Q; Sun X; Yang J; Wang H; Zhang D
FEBS Open Bio; 2021 Sep; 11(9):2490-2506. PubMed ID: 34184409
[TBL] [Abstract][Full Text] [Related]
17. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
19. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
20. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
